NEW YORK (GenomeWeb) – Thermo Fisher Scientific disclosed in a filing yesterday with the US Securities and Exchange Commission the purchase price for its recent acquisitions of Core Informatics and Finesse Solutions, as well as the settlement earlier this year of three patent lawsuits involving DNA sequencing technology from Roche 454 Life Sciences and Illumina.
Menu
Home » Thermo Fisher Spent $314M on Two Acquisitions in Q1; Settled IP Suits With Roche 454, Illumina
Thermo Fisher Spent $314M on Two Acquisitions in Q1; Settled IP Suits With Roche 454, Illumina
May 11, 2017
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
What's Popular?
In Business News